Curaleaf Holdings Buys Out Minority Partner in Curaleaf International

*STAMFORD, Conn. —* Curaleaf Holdings Inc., a leading international
provider of consumer cannabis products, acquired the equity stake in
Curaleaf International Holdings Limited previously held by a single
strategic institutional investor. The transaction brings the Company’s
stake in its European holding company to 100%.

Financial details of the transaction were not disclosed.

The transaction represents the completion of a Put/Call Option that was
agreed with the strategic investor at the time of its participation in
Curaleaf’s move into Europe in 2021. Following the pricing mechanism
incorporated in the Put/Call Option, the investor elected to receive the
purchase entirely in Curaleaf Subordinate Voting Shares.

The acquisition strengthens the Company’s control over its European
operations, enabling enhanced strategic alignment across international
markets. The request of the strategic investor to settle the transaction
for Company shares underscores the investor’s long-term support and
confidence in the future of Curaleaf.

The issuance of the Subordinate Voting Shares in connection with the
transaction was conditionally approved by the Toronto Stock Exchange on
June 25, subject to fulfilling customary listing conditions. The
transaction was completed on July 2.

Boris Jordan, Executive Chairman of Curaleaf Holdings Inc.,
commented, “This consolidation of ownership of our European holding company
enables us to streamline decision-making, strengthen alignment across
regions, and accelerate our strategic initiatives in Europe with greater
autonomy. This development marks another important milestone in Curaleaf’s
continued commitment to international expansion and long-term value
creation for shareholders. We thank our partners for their long-standing
support and belief in Curaleaf’s future.”
About Curaleaf Holdings

Curaleaf Holdings Inc. (TSX: CURA) (OTCQX: CURLF) is a leading
international provider of consumer products in cannabis with a mission to
enhance lives by cultivating, sharing and celebrating the power of the
plant. The Company and its brands, including Curaleaf, Select, Grassroots,
Find, Anthem, and The Hemp Company, provide service, product selection, and
accessibility across the medical and adult use markets. Curaleaf
International is powered by a strong presence in all stages of the supply
chain. Its unique distribution network throughout Europe, Canada and
Australasia brings together pioneering science and research with
cultivation, extraction, and production.
About Curaleaf International

Curaleaf International’s network includes a clinic, pharmacy, and
laboratory in the UK; cultivation and EU-GMP processing facilities in
Portugal; an EU-GMP processing, quality assurance and research site in
Spain; Four20 Pharma wholesaler and distributor in Germany; a Polish
wholesaler and clinic; and the EU-GMP producer Northern Green Canada.